Vanguard Capital Management’s Kezar Life Sciences KZR Stock Holding History

Vanguard Capital Management’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-290,529	Closed	-$2.16M	–	4126
2026 Q1	$2.16M	Buy	+290,529	New	+$1.89M	﹤0.01%	3342

Vanguard Capital Management's KZR Position: Q2 2026 in Review

Vanguard Capital Management sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 290,529 shares — an estimated $2.16M sold.

Vanguard Capital Management first reported a position in KZR in Q1 2026 and held it in 1 quarter. The position peaked at $2.16M in Q1 2026. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.

Vanguard Capital Management reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
Vanguard Capital Management sold 290,529 Kezar Life Sciences shares in Q2 2026, an estimated $2.16M.
Vanguard Capital Management first reported a position in Kezar Life Sciences in Q1 2026 and held it in 1 quarter.
Vanguard Capital Management's Kezar Life Sciences position peaked at $2.16M in Q1 2026.
0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.